The hypothetical pathological cascade of AD postulates an initial accumulation of extracellular amyloid-β, followed by tau aggregation and synaptic dysfunction, subsequently leading to downstream tau-mediated neurodegeneration and cognitive impairment (Jack et al., 2010; Therriault et al., 2024). The gene discussed is MAPT; the disease is Cognitive impairment.